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Background
Cerebral malaria (CM) is a fatal complication of P. falci-
parum infection caused by the cytoadherence of infected
erythrocytes to brain endothelial cells followed by micro-
circulatory obstruction, blood-brain barrier (BBB)
damage, ring hemorrhages, inflammatory response and
neurological sequelae. The combination of both parasite
and host factors are involved in the pathogenesis of CM.
In particular, malarial pigment, hemozoin (HZ) was
shown to interfere with monocytes and endothelial cell
functions. Recently our group demonstrated that HZ
enhanced total gelatinolytic activity in endothelial cells
by inducing ex novo matrix metalloproteinases-9 (MMP-
9) and promoting proMMP-9 protein expression (Prato
et al., 2011).
Materials and methods
In the present work human dermal microvascular
endothelial cells (HMEC-1) were treated with native HZ
isolated from P.flaciparum cultures. Cell morphology was
evaluated by optical microscopy, chemokine (CXCL-8,
CCL-5) production by ELISA, proliferation/viability by
MTT assay and trypan blue count, apoptosis and cell cycle
by FACS analysis, using Annexin Vl Propidium Iodide (PI)
and only PI, respectively.
Results
Modifications of cell morphology were observed in HZ-
treated cells, which showed elongated form instead of the
classical polygonal shape. Moreover, HZ stimulated the
production of the chemokines CXCL-8 and CCL-5,
involved in neutrophils/monocytes recruitment, in a dose
and time-dependent manner. After 48-72 hours of culture
in the presence of HZ, a reduction of cells number/prolif-
eration, compared to the control, was observed. However,
FACS analysis indicated that HZ treatment did not induce
apoptosis of endothelial cells. On the contrary, HZ
increased the percentage of GO/G1-phase cells and
decreased S-phase cells, indicating a reduction of the
growth fraction cells.
Conclusions
The present data suggest that HZ promotes chemokines
release and inhibits endothelial cells growth. As a conse-
quence, neutrophils/monocytes recruitment is favoured
resulting in the amplification of the inflammatory
response. Moreover, in case of vascular injury, the
damaged monolayer could not be regenerated by prolifer-
ating endothelial cells. All these events may concur to
impair BBB functions in CM.
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